Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,128,471
+$4,058,147 QoQ
Shares Held
526,475
+2.7% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,128,471 | 526,475 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,070,324 | 512,575 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,675,162 | 512,575 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,384,589 | 504,175 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,771,030 | 492,875 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,428,248 | 498,875 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,555,115 | 506,375 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,600,868 | 501,875 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,426,072 | 503,675 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,469,090 | 503,675 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $7,262,993 | 503,675 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,733,318 | 560,675 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,526,138 | 553,875 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $12,911,892 | 548,975 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $17,153,907 | 614,175 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $14,074,515 | 601,475 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $20,158,031 | 597,275 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $20,939,661 | 599,475 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $16,990,338 | 557,975 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $18,335,348 | 559,175 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $16,981,155 | 561,175 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||